Danish pharmaceutical company Novo Nordisk recently announced plans to spend approximately $1.2 billion to build a new production facility in Odense, Denmark.
This large and complex expansion of a biologic medicine manufacturing plant increased capacity 75% by adding three production bioreactors, each 15,400 liters, as well as associated seed reactors and expanded warehouse cold rooms, freezers and central utilities.
Skanska will be responsible for the lift portion of a replacement for the Raritan River rail bridge, while work on the approaches is underway under a separate contract.
Kolluri was most recently CEO of the Gateway Development commission, where he led rail infrastructure projects that will serve NJ Transit's commuter rail.